JPY 610.0
(-0.65%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - JPY | 0.0% |
2022 | - JPY | 0.0% |
2021 | - JPY | 0.0% |
2020 | - JPY | 0.0% |
2019 | - JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - JPY | 0.0% |
2023 Q2 | - JPY | 0.0% |
2023 Q4 | - JPY | 0.0% |
2023 Q3 | - JPY | 0.0% |
2023 FY | - JPY | 0.0% |
2023 Q1 | - JPY | 0.0% |
2022 Q3 | - JPY | 0.0% |
2022 FY | - JPY | 0.0% |
2022 Q4 | - JPY | 0.0% |
2022 Q2 | - JPY | 0.0% |
2021 FY | - JPY | 0.0% |
2020 FY | - JPY | 0.0% |
2019 FY | - JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Kyowa Kirin Co., Ltd. | 24.24 Billion JPY | 100.0% |
Astellas Pharma Inc. | 1005.71 Billion JPY | 100.0% |
Chugai Pharmaceutical Co., Ltd. | 13.45 Billion JPY | 100.0% |
Ono Pharmaceutical Co., Ltd. | 8.86 Billion JPY | 100.0% |
Santen Pharmaceutical Co., Ltd. | 35.15 Billion JPY | 100.0% |
JCR Pharmaceuticals Co., Ltd. | 23.3 Billion JPY | 100.0% |
Daiichi Sankyo Company, Limited | 156 Billion JPY | 100.0% |
Otsuka Holdings Co., Ltd. | 214.18 Billion JPY | 100.0% |